72893-016-02 : NDC 2026 Code

72893-016-02 : Efbemalenograstim Alfa-vuxw ( Ryzneuta )

Additionally :

You can get information about “72893-016-02” NDC code in 72893-016-02 in HTML format

HTML | 72893-016-02 in TXT (Plain Text) format

TXT | 72893-016-02 in PDF (Portable Document Format)

PDF | 72893-016-02 in XML format

XML formats.

NDC Code : 72893-016-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "72893-016-02",
    "PackageDescription": "1 SYRINGE in 1 CARTON (72893-016-02)  / 1 mL in 1 SYRINGE",
    "NDC11Code": "72893-0016-02",
    "ProductNDC": "72893-016",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Ryzneuta",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Efbemalenograstim Alfa-vuxw",
    "DosageFormName": "INJECTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20231123",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761134",
    "LabelerName": "Acrotech Biopharma Inc",
    "SubstanceName": "EFBEMALENOGRASTIM ALFA",
    "StrengthNumber": "20",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Colony-Stimulating Factors [CS], Leukocyte Growth Factor [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-29",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20231123",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}